<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our results for 18 patients undergoing matched sibling donor stem cell transplant for Fanconi <z:hpo ids='HP_0001903'>anaemia</z:hpo> at Cincinnati Children's Hospital Medical Center were published in 1994 </plain></SENT>
<SENT sid="1" pm="."><plain>The present report updates our results in 35 consecutive patients </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty patients transplanted for marrow <z:mpath ids='MPATH_58'>aplasia</z:mpath> received <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> 5 mg/kg for 4 d and 400 cGy thoraco-abdominal irradiation </plain></SENT>
<SENT sid="3" pm="."><plain>Five patients with clones involving chromosome 7, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> or <z:mpath ids='MPATH_336'>leukaemia</z:mpath> received a more aggressive regimen with total body irradiation </plain></SENT>
<SENT sid="4" pm="."><plain>Horse antithymocyte globulin was administered in the pretransplant period to promote engraftment and in the post-transplant period for additional <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD) prophylaxis </plain></SENT>
<SENT sid="5" pm="."><plain>The median age at bone marrow transplantation was 7.6 years </plain></SENT>
<SENT sid="6" pm="."><plain>Median day of engraftment was day +12 (range 9-49), eight patients developed <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD and four <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD, one limited and three extensive </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty-nine of 35 patients (89% actuarial survival at 10 years) had survived with a median follow up of 10.2 years; two children had developed <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">secondary malignancy</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> surviving patients had <z:mpath ids='MPATH_458'>normal</z:mpath> blood counts with full donor engraftment </plain></SENT>
<SENT sid="9" pm="."><plain>These data indicate excellent long-term outcomes and serve as a reference for newer radiation-free preparative regimes that may reduce the risk of late <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">secondary malignancy</z:e> </plain></SENT>
</text></document>